Celltrion Widens Europe Share, Eyes Profit Beat
Celltrion is further solidifying its local influence in Europe based on the prescription growth of its entire product lineup. According to the pharmaceutical market research firm IQVIA, Remsima, Celltrion’s flagship autoimmune disease treatment, recorded …